VHAC Bi-Annual Meeting | Friday, November 13, 2015


The CDC Foundation convened the Bi-Annual Viral Hepatitis Action Coalition (VHAC) Partner Meeting in San Francisco, CA on November 13, 2015 with a focus of international and U.S. domestic prevention of viral hepatitis. The meeting agenda focused on national-level elimination planning, expanding access to therapies, improving the hepatitis care cascades, and setting elimination targets.


Below please find links to presentations from the Meeting for each speaker. Additional meeting materials include the meeting agenda, presenter biosketches, and the participant list.


Session 1: Charting a Path Forward Globally

Towards the Elimination of Hepatitis B and C by 2030: The Draft WHO Global Hepatitis Strategy, 2016-2021 and Global Elimination Targets

Stefan Wiktor, M.D., M.P.H.

Medical Officer, Team Lead

Global Hepatitis Programme, World Health Organization


National-Level Elimination of Hepatitis C: The Country of Georgia Experience

Valeri Kvaratskhelia, M.D.

Deputy Minister,

Ministry of Labour, Health, and Social Affairs of Georgia


HepCure: 2nd Hepatitis Cure & Eradication Meeting

Jordan Feld, M.D., M.P.H.


Toronto Western Hospital Liver Clinic, and

McLaughlin-Rotman Centre for Global Health


Expanding Access to Hepatitis C Therapies: Lessons Learned from the HIV Experience

and Improving Access to Hepatitis C Therapy Globally

Brian Honermann, J.D.

Senior Research Advisor,

amfAR, The Foundation for AIDS Research


CDC Division of Viral Hepatitis (DVH): Global Viral Hepatitis Update

Francisco Averhoff, M.D., M.P.H.

Associate Director for Global Health,

DVH, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP),

Centers for Disease Control and Prevention (CDC)


Session 2: United States Priorities to Prevent Transmission and Disease

Improving Hepatitis C Detection and Linkage to Care among Persons Who Inject Drugs

Scott Holmberg, M.D., M.P.H.

Chief, Epidemiology and Surveillance Branch



Improving Viral Hepatitis Care Cascades

Susan Hariri, Ph.D.

Scientific Deputy, Prevention Branch



Improving Access to Outbreak Investigations & Quality Hepatitis C Diagnostics

Saleem Kamili, Ph.D.

Acting Deputy Branch Chief, Laboratory Branch



Cherokee Nation Health Services HCV Elimination Project

Jorge Mera, M.D.

Infectious Diseases Specialist,

Cherokee Nation W.W. Hastings Indian Hospital


Placing the Nation on the Path toward the Elimination of Hepatitis C

John Ward, M.D.




Session 3: Contributions to Viral Hepatitis Prevention - Local Collaborations

The Birth-Cohort Evaluation to Advance Screening and Testing for

Hepatitis C (BEST-C) Studies

David Rein, Ph.D., M.P.A.

Program Area Director,

Public Health Analytics Division,

NORC at the University of Chicago


Findings from the Chronic Hepatitis Cohort Study (‘CHeCS’)

Stuart Gordon, M.D.

Director of Hepatology,

Henry Ford Health Systems